Immunotherapy for HNSCC: an emerging paradigm?

被引：0
|
作者：
Guigay, J. [1 ]
机构：
[1] Ctr Antoine Lacassagne, Nice, France
来源：
RADIOTHERAPY AND ONCOLOGY | 2016年 / 119卷
关键词：
D O I：
10.1016/S0167-8140(16)31658-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SP-0409
引用
收藏
页码：S190 / S191
页数：2
相关论文
共 50 条
  • [1] Combination Immunotherapy: An Emerging Paradigm in Cancer Therapeutics
    Wang, Daniel Y.
    Sosman, Jeffrey A.
    Johnson, Douglas B.
    ONCOLOGY-NEW YORK, 2015, 29 (12): : 1005 - 1006
  • [2] Immunotherapy for HNSCC. Quo vadis?
    Doescher, J.
    Busch, C-J.
    Schuler, P. J.
    Laban, S.
    HNO, 2016, 64 (10) : 700 - 707
  • [3] HNSCC: Tumour Antigens and Their Targeting by Immunotherapy
    von Witzleben, Adrian
    Wang, Chuan
    Laban, Simon
    Savelyeva, Natalia
    Ottensmeier, Christian H.
    CELLS, 2020, 9 (09)
  • [4] Review of biomarkers for response to immunotherapy in HNSCC microenvironment
    Chen, Shaoshi
    Yang, Yifan
    He, Shizhi
    Lian, Meng
    Wang, Ru
    Fang, Jugao
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [5] The emerging role of immunotherapy in head and neck squamous cell carcinoma (HNSCC): anti-tumor immunity and clinical applications
    Economopoulou, Panagiota
    Perisanidis, Christos
    Giotakis, Evaggelos I.
    Psyrri, Amanda
    ANNALS OF TRANSLATIONAL MEDICINE, 2016, 4 (09)
  • [6] Photon-Driven Dye Induction Pyroptosis: An Emerging Anti-Tumor Immunotherapy Paradigm
    Zeng, Shuang
    Wang, Jingyun
    Kang, Heemin
    Li, Haidong
    Peng, Xiaojun
    Yoon, Juyoung
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2025, 64 (02)
  • [7] Why Immunotherapy Will Become the New Standard of Care in HNSCC
    Steuer, Conor
    ONCOLOGY-NEW YORK, 2018, 32 (12): : 618 - 618
  • [8] PD-1 immunotherapy for recurrent or metastatic HNSCC
    Ferris, Robert L.
    Licitra, Lisa
    LANCET, 2019, 394 (10212): : 1882 - 1884
  • [9] Unravelling the molecular signatures in HNSCC: Is the homogenous paradigm becoming obsolete?
    Gopinath, Divya
    Menon, Rohit Kunnath
    ORAL ONCOLOGY, 2018, 82 : 195 - 195
  • [10] Cancer immunotherapy: an evolving paradigm
    Lin, Aifu
    JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B, 2022, 23 (10): : 791 - 792
12345